NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine -

When's the last time your MD gave you a generic drug sample?

Posted By



Don’t hold your breath. It’s not going to happen.

Meantime, in one more way brand name drug makers promote their brand to doctors and patients – they are giving out $3 billion a year of their samples!

Katie Hobson on the Wall Street Journal HealthBlog writes:

To (roughly) put that in the larger context of pharma marketing, the (Congressional Budget Office) CBO reported last year that the drug industry spent “at least $20.5 billion” on other forms of marketing in 2008. Most of that, some $12 billion, not counting the cost of samples, went towards sales rep visits to doctors.

The CBO estimated that the industry also spent $4.7 billion on direct-to-consumer ads, $3.4 billion on event and meeting sponsorships and $400 million on advertising to docs, in journals.

You might also like

Comments (2)

Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.

Deborah Walsh

June 7, 2010 at 8:59 am

I know many of us providers grumble at the cost of some of the drugs, when most of the generics are tried and true performers. However, those pesky samples can be a boon for those without insurance.